VCM
YARW

Vanguard Capital Management’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Vanguard Capital Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$158K Buy
+5,291
New +$154K ﹤0.01% 3822

Other funds holding YARW

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Vanguard Capital Management's YARW Position: Q1 2026 in Review

Vanguard Capital Management opened a new position in Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2026: 5,291 shares worth $158K. The stake represents ﹤0.01% of the portfolio and ranks #3822 among its holdings.

42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

  • Vanguard Capital Management held 5,291 shares of Yarrow Bioscience, Inc. Common Stock worth $158K as of Q1 2026.
  • Yarrow Bioscience, Inc. Common Stock was a new Vanguard Capital Management position in Q1 2026.
  • Yarrow Bioscience, Inc. Common Stock made up ﹤0.01% of Vanguard Capital Management's portfolio in Q1 2026, its #3822 holding.
  • 42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on Vanguard Capital Management's 13F filing for Q1 2026, filed 8 May 2026.